Detalhe da pesquisa
1.
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.
Int J Gynecol Cancer
; 32(6): 753-760, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063943
2.
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.
Breast Cancer Res Treat
; 181(1): 97-105, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240454